Solventum Corp. shares fall 1.51% for second day, underperforming market

8 articles · Updated · MarketWatch · Apr 29

Solventum Corp. stock closed at $66.49 on Wednesday, down 1.51%, with trading volume at 1.1 million shares, below its 50-day average.
The decline occurred during a broadly negative session, as the S&P 500 slipped 0.04% and the Dow Jones fell 0.57%.
Solventum shares are now 24.61% below their 52-week high of $88.20, reached on December 2, marking two consecutive days of losses.

With solid earnings and a positive outlook, why is Solventum's stock still so undervalued?

How will cost-cutting plans affect Solventum's long-term R&D and market leadership?

Despite positive guidance, what major risks could derail Solventum's projected 2026 growth?

Can Solventum's AI strategy overcome the severe financial pressures facing its hospital customers?

Will the $1 billion share buyback be enough to reverse the stock's recent decline?